Colorado homes may hold a silent, odorless and radioactive gas: radon. Seeping up through the ground, it can collect in homes ...
Background: Despite undergoing surgery and chemoradiotherapy, patients with first primary lung cancer (FPLC) remain at risk for second primary lung cancer (SPLC), which is associated with a poor ...
Engr. Emer Rojas, LungHAP President, and lung cancer survivor, spoke about the need to identify champions—be they from government, patient communities, or the medical field—to spearhead the ...
In 2018, she was diagnosed with stage 3A lung cancer and given a grave ... infusions and since 2020 has shown no evidence of cancer. Heidi and her husband, Dr. Pierre Onda, started the nonprofit White ...
Wed, January 22, 2025 at 2:10 AM UTC New bird flu variant found in Nevada dairy cows has experts sounding alarms: ‘We have never been closer to a pandemic from this virus’ ...
The most common cancers in women are projected to be breast cancer (32%), lung and bronchus cancer (12%), and colorectal cancer (7%). The most common cancers in men are projected to be prostate ...
The ribbon was snipped last week to celebrate the completion of the first phase of a new $60 million Cancer Center at the UW Medicine Valley Medical Center in Renton.
Actress Susan Sullivan, 82, who announced she was “cancer-free” from non-small cell lung cancer (the most common type of ... with one supporter commenting, “As a cancer survivor, sending good healing ...
That put Jackson, a cancer survivor, on the path to launching the Center for Food Equity in Medicine. The nonprofit works to address food insecurity among cancer patients, says Jackson ...
A mum-of-three and breast cancer survivor is now fighting for her life less than 12 months after receiving a clean bill of health. Miriam Gard, 43, had her first brush with cancer at only 26 ...
While in treatment, the cancer caused severe damage to her lungs leading her to need a double lung transplant. “I was on oxygen 24/7 and I was basically homebound,” Gorman told us. Before ...
A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation. A major new ...